Publication: Analytical performance of centrifuge-based device for clinical chemistry testing
Issued Date
2012-12-31
Resource Type
ISSN
14336510
Other identifier(s)
2-s2.0-84871568305
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Laboratory. Vol.58, No.11-12 (2012), 1313-1318
Suggested Citation
Jamikorn Suk-Anake, Chamras Promptmas Analytical performance of centrifuge-based device for clinical chemistry testing. Clinical Laboratory. Vol.58, No.11-12 (2012), 1313-1318. doi:10.7754/Clin.Lab.2012.120705 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/13542
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Analytical performance of centrifuge-based device for clinical chemistry testing
Author(s)
Other Contributor(s)
Abstract
Background: A centrifuge-based device has been introduced to the Samsung Blood Analyzer (SBA). The verification of this analyzer is essential to meet the ISO15189 standard. Methods: Analytical performance was evaluated according to the NCCLS EP05-A method. The results of plasma samples were compared between the SBA and a Hitachi 917 analyzer according to the NCCLS EP09-A2-IR method. Percent recovery was determined via analysis of original control serum and spiked serum. Results: Within-run precision was found to be 0.00-6.61% and 0.96-5.99% in normal- and abnormal-level assays, respectively, while between-run precision was 1.31-9.09% and 0.89-6.92%, respectively. The correlation coefficients (r) were > 0.990. The SBA presented analytical accuracy at 96.64 ± 3.39% to 102.82 ± 2.75% and 98.31 ± 4.04% to 103.61 ± 8.28% recovery, respectively. Conclusions: The results obtained verify that all of the 13 tests performed using the SBA demonstrates good and reliable precision suitable for use in qualified clinical chemistry laboratory service.